久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/06/21 | 9,760 | 9,920 | 9,720 | 9,750 | -80 | -0.8% | 182,100 |
2018/06/20 | 9,730 | 9,850 | 9,670 | 9,830 | +160 | +1.7% | 154,000 |
2018/06/19 | 9,650 | 9,870 | 9,610 | 9,670 | -10 | -0.1% | 166,700 |
2018/06/18 | 9,620 | 9,720 | 9,570 | 9,680 | +90 | +0.9% | 101,400 |
2018/06/15 | 9,390 | 9,610 | 9,370 | 9,590 | +260 | +2.8% | 268,900 |
2018/06/14 | 9,300 | 9,390 | 9,240 | 9,330 | -120 | -1.3% | 147,200 |
2018/06/13 | 9,230 | 9,500 | 9,230 | 9,450 | +220 | +2.4% | 135,800 |
2018/06/12 | 9,080 | 9,240 | 8,970 | 9,230 | +150 | +1.7% | 135,000 |
2018/06/11 | 9,100 | 9,170 | 9,050 | 9,080 | ±0 | ±0% | 113,200 |
2018/06/08 | 9,120 | 9,240 | 9,060 | 9,080 | -130 | -1.4% | 221,300 |
2018/06/07 | 9,420 | 9,460 | 9,140 | 9,210 | -140 | -1.5% | 235,600 |
2018/06/06 | 9,490 | 9,500 | 9,250 | 9,350 | -180 | -1.9% | 154,700 |
2018/06/05 | 9,480 | 9,570 | 9,380 | 9,530 | +50 | +0.5% | 156,800 |
2018/06/04 | 9,400 | 9,530 | 9,300 | 9,480 | +230 | +2.5% | 122,200 |
2018/06/01 | 9,070 | 9,460 | 9,060 | 9,250 | +190 | +2.1% | 285,000 |
2018/05/31 | 8,880 | 9,060 | 8,860 | 9,060 | +260 | +3% | 517,500 |
2018/05/30 | 8,900 | 9,010 | 8,790 | 8,800 | -250 | -2.8% | 162,400 |
2018/05/29 | 8,970 | 9,110 | 8,940 | 9,050 | +170 | +1.9% | 136,300 |
2018/05/28 | 9,020 | 9,020 | 8,860 | 8,880 | -110 | -1.2% | 83,600 |
2018/05/25 | 9,000 | 9,090 | 8,940 | 8,990 | -30 | -0.3% | 93,200 |
2018/05/24 | 8,870 | 9,140 | 8,860 | 9,020 | +240 | +2.7% | 239,900 |
2018/05/23 | 8,770 | 8,950 | 8,740 | 8,780 | -80 | -0.9% | 170,000 |
2018/05/22 | 8,930 | 8,930 | 8,800 | 8,860 | -50 | -0.6% | 101,500 |
2018/05/21 | 8,960 | 9,000 | 8,880 | 8,910 | -60 | -0.7% | 70,400 |
2018/05/18 | 8,910 | 9,040 | 8,840 | 8,970 | +100 | +1.1% | 122,200 |
2018/05/17 | 8,890 | 8,910 | 8,770 | 8,870 | +90 | +1% | 99,700 |
2018/05/16 | 8,690 | 8,890 | 8,680 | 8,780 | -20 | -0.2% | 119,800 |
2018/05/15 | 8,900 | 8,980 | 8,780 | 8,800 | ±0 | ±0% | 147,900 |
2018/05/14 | 8,750 | 8,880 | 8,670 | 8,800 | +150 | +1.7% | 151,700 |
2018/05/11 | 8,610 | 8,810 | 8,600 | 8,650 | +20 | +0.2% | 155,600 |
2018/05/10 | 8,590 | 8,660 | 8,480 | 8,630 | -20 | -0.2% | 147,400 |
2018/05/09 | 8,790 | 8,800 | 8,600 | 8,650 | -250 | -2.8% | 191,900 |
2018/05/08 | 8,910 | 8,990 | 8,830 | 8,900 | +140 | +1.6% | 191,600 |
2018/05/07 | 8,620 | 8,760 | 8,570 | 8,760 | +160 | +1.9% | 159,000 |
2018/05/02 | 8,540 | 8,620 | 8,450 | 8,600 | -30 | -0.3% | 111,000 |
2018/05/01 | 8,450 | 8,640 | 8,400 | 8,630 | +100 | +1.2% | 138,000 |
2018/04/27 | 8,500 | 8,730 | 8,440 | 8,530 | +100 | +1.2% | 224,000 |
2018/04/26 | 8,330 | 8,460 | 8,240 | 8,430 | +250 | +3.1% | 241,100 |
2018/04/25 | 7,970 | 8,250 | 7,970 | 8,180 | +160 | +2% | 133,300 |
2018/04/24 | 7,930 | 8,040 | 7,900 | 8,020 | +150 | +1.9% | 113,200 |
2018/04/23 | 7,920 | 7,990 | 7,840 | 7,870 | -60 | -0.8% | 96,600 |
2018/04/20 | 7,800 | 7,990 | 7,770 | 7,930 | +60 | +0.8% | 127,000 |
2018/04/19 | 8,080 | 8,080 | 7,870 | 7,870 | -180 | -2.2% | 118,800 |
2018/04/18 | 8,050 | 8,070 | 7,960 | 8,050 | +90 | +1.1% | 95,200 |
2018/04/17 | 7,920 | 8,030 | 7,900 | 7,960 | -10 | -0.1% | 121,000 |
2018/04/16 | 7,680 | 8,050 | 7,650 | 7,970 | +370 | +4.9% | 173,500 |
2018/04/13 | 7,770 | 7,770 | 7,570 | 7,600 | -180 | -2.3% | 213,100 |
2018/04/12 | 8,090 | 8,110 | 7,760 | 7,780 | -280 | -3.5% | 271,400 |
2018/04/11 | 8,110 | 8,220 | 7,830 | 8,060 | -480 | -5.6% | 387,900 |
2018/04/10 | 8,600 | 8,690 | 8,440 | 8,540 | -90 | -1% | 149,700 |
1751~
1800
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 322,600円 | +3.6% | -15.3% | 3.84% | 9.06倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム